Latest Glucose-6-phosphate dehydrogenase deficiency Stories
In malaria-endemic countries, 350 million people are predicted to be deficient in an enzyme that means they can suffer severe complications from taking primaquine, a key drug for treating relapsing malaria.
The gene for the protein p53 is the most frequently mutated in human cancer.
New research in the FASEB Journal reports that the G6PD protein, which produces the essential antioxidant NAPDH, could prevent the death of pancreatic beta cells, the root cause of diabetes.
ACZONE(R) Gel 5% is the First New FDA-Approved Chemical Entity for Topical Acne Treatment in a Decade CARLSBAD, Calif., May 11 /PRNewswire/ -- SkinMedica, Inc.
By Cooper, R G Magwere, T Chloroquine (CHQ) is a cheap, relatively well tolerated drug initially developed for the treatment of malaria in the 1930s.